Published in J Hypertens on December 01, 1996
Reproducibility of blood pressure responses to dietary sodium and potassium interventions: the GenSalt study. Hypertension (2013) 1.59
Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective. Front Physiol (2015) 0.77
Salt, resting arterial pressure and 24 h monitoring. J Hypertens (1997) 0.75
Clinical versus experimental utility of salt-sensitivity testing. J Hypertens (1997) 0.75
An Appraisal of Methods Recently Recommended for Testing Salt Sensitivity of Blood Pressure. J Am Heart Assoc (2017) 0.75
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet (2002) 2.92
Low triiodothyronine and survival in end-stage renal disease. Kidney Int (2006) 1.88
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol (2001) 1.83
Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol (2001) 1.54
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol (2001) 1.46
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant (2001) 1.12
Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int (1998) 1.07
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens (2000) 1.01
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med (2003) 0.99
Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med (2007) 0.97
AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant (2000) 0.97
Sleep apnea in renal patients. J Am Soc Nephrol (2001) 0.92
Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens (1999) 0.91
Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant (2001) 0.88
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest (2003) 0.88
Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med (2007) 0.88
Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension. Am J Hypertens (2001) 0.87
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease. Kidney Int (2006) 0.86
Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension. J Nephrol (2000) 0.86
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis (2011) 0.86
Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol (1986) 0.86
Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients. J Hypertens (2001) 0.84
Adiponectin and renal disease progression: another epidemiologic conundrum? Kidney Int (2007) 0.84
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. Am J Hypertens (2000) 0.83
Sleep disordered breathing in renal transplant patients. Am J Transplant (2009) 0.83
Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease. Nephrol Dial Transplant (1995) 0.82
Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis (2000) 0.81
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol (1999) 0.80
Plasma met-enkephalin and leu-enkephalin in chronic renal failure. Nephrol Dial Transplant (1987) 0.79
Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney Int (2007) 0.79
Does high salt intake cause hyperfiltration in patients with essential hypertension? J Hum Hypertens (1996) 0.79
Management of hypertension in chronic kidney disease: the Italian multicentric study. J Nephrol (2005) 0.79
The reflex control of vasopressin in haemodialysis patients. Nephrol Dial Transplant (1991) 0.79
Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients. J Nephrol (2001) 0.78
Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens (2000) 0.78
The role of endogenous opioids in the baroreflex dysfunction of dialysis patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.78
Randomly allocated crossover study of various levels of sodium intake in patients with mild hypertension. J Hypertens Suppl (1993) 0.77
Does adipose tissue have a key role in inflammation in CKD? J Intern Med (2011) 0.77
Postprandial alterations in arterial pressure control during hemodialysis in uremic patients. Clin Nephrol (1989) 0.77
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD). Nutr Metab Cardiovasc Dis (2011) 0.77
The salt epidemic: old and new concerns. Nutr Metab Cardiovasc Dis (2000) 0.77
Double-blind randomized, crossover trial of calcium supplementation in essential hypertension. J Hypertens (1988) 0.76
Assessment of the salt-arterial pressure relationship in mild hypertensive subjects by 24-hour ambulatory monitoring. Clin Sci (Lond) (1994) 0.76
Does ambulatory monitoring make saltier salt sensitivity studies? J Hypertens (1997) 0.75
Pulmonary embolism in chronic kidney disease: a lethal, overlooked and research orphan disease. J Thromb Haemost (2012) 0.75
A green light for troponin T in the cardiovascular risk stratification of continuous ambulatory peritoneal dialysis patients? Kidney Int (2006) 0.75
Salt intake and hyperfiltration. Hypertension (1996) 0.75
Parasympathetic function in haemodialysis patients. Nephron (1986) 0.75
Homocysteine and risk in end-stage renal disease: a matter of context. Kidney Int (2006) 0.75
Failure of AVP and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1996) 0.75
Updating the lipids hypothesis of inflammation and vascular disease in patients with chronic kidney disease: a stearoyl-CoA desaturase affair? J Intern Med (2012) 0.75
Low triiodothyronine: a pathway to coronary calcification in patients maintained on peritoneal dialysis. J Intern Med (2013) 0.75
Mechanism of hypercalciuria in essential hypertension and in primary nephrolithiasis. Contrib Nephrol (1991) 0.75
The heart rate response pattern to dialysis hypotension in haemodialysis patients. Nephrol Dial Transplant (1997) 0.75
Diabetes and end-stage renal failure. Lancet (1987) 0.75
[OP.2B.05] LONG TERM, BUT NOT SHORT TERM, BLOOD PRESSURE VARIABILITY PREDICTS CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS. J Hypertens (2016) 0.75
Effects of Continuous kinaesthetic feedback based on tendon vibration on Motor Imagery BCI performance. IEEE Trans Neural Syst Rehabil Eng (2017) 0.75
[OP.4D.08] DISORDERED SLEEP BREATHING (SDB) IS THE MAJOR DETERMINANT OF NON-DIPPING AND NOCTURNAL HYPERTENSION IN KIDNEY TRANSPLANT PATIENTS. J Hypertens (2016) 0.75
Influence of extracellular volume expansion on circulating PTH1-84 in subjects with mild essential hypertension. Am J Hypertens (1994) 0.75
[GIN changes typographical format and objectives]. G Ital Nefrol (2004) 0.75
Diabetes and renal failure: a southern Italian perspective. J Diabet Complications (1989) 0.75
Hyperfiltration and calcium metabolism in essential hypertension. Am J Hypertens (1991) 0.75
Effect of ultrafiltration on plasma concentrations of atrial natriuretic peptide in haemodialysis patients. Nephrol Dial Transplant (1986) 0.75
The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension. J Hypertens (1994) 0.75
[Functional relationships between plasma renin activity and hemodynamic indices in essential arterial hypertension]. Boll Soc Ital Biol Sper (1980) 0.75
[Prevalence of insulin-dependent and non-insulin-dependent diabetes among Italian patients on replacement therapy. Preliminary survey at 3 dialysis centers]. Minerva Urol Nefrol (1991) 0.75
The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis. Clin Nephrol (1992) 0.75
Effect of naloxone on the defective autonomic control of heart rate in uraemic patients. Clin Sci (Lond) (1985) 0.75
4A.04: EFFECTS OF RENAL DENERVATION ON ASYMMETRIC DIMETHYLARGININE AND SYMPATHETIC NERVE TRAFFIC IN RESISTANT HYPERTENSIVE PATIENTS. J Hypertens (2015) 0.75
The alarm reaction to blood pressure measurement in dialysis patients. Contrib Nephrol (1996) 0.75
[Cardiac output and pulmonary blood volume in arterial hypertension of chronic uremia]. Boll Soc Ital Biol Sper (1980) 0.75
Is Metenkephalin responsible for the baroreflex dysfunction of chronic uraemics? Clin Exp Hypertens A (1984) 0.75